Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/03/2012CN101001670B Compositions for sleeping disorders
10/02/2012USRE43711 Pulmonary delivery for levodopa
10/02/2012US8278485 Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides
10/02/2012US8278482 Antimicrobial N-chlorinated compositions
10/02/2012US8278473 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same
10/02/2012US8278469 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
10/02/2012US8278462 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/02/2012US8278460 Substituted benzimidazoles
10/02/2012US8278458 Oral bioavailability; minimal toxicity; low concentration in the kidneys after administration; reduce oxidative stress; (S)-4,5-Dihydro-2-[2-hydroxy-4-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid; condition responsive to chelation or sequestration of a trivalent metal
10/02/2012US8278457 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
10/02/2012US8278455 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
10/02/2012US8278451 Pseudoazulenyl nitrones
10/02/2012US8278441 BACE inhibitors
10/02/2012US8278436 Glycosylated warfarin analogs and uses thereof
10/02/2012US8278435 N-pyrazole A2A receptor agonists
10/02/2012US8278427 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278417 Kits for treating wounds
10/02/2012US8278359 Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
10/02/2012US8278358 Lipoic acid derivatives
10/02/2012US8278357 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
10/02/2012US8278356 Phloroglucinol derivatives having selectin ligand activity
10/02/2012US8278354 Method for increasing ruminant fertility
10/02/2012US8278353 Enhanced bimatoprost ophthalmic solution
10/02/2012US8278351 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
10/02/2012US8278350 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer
10/02/2012US8278349 Cancer treatment using FTS and 2-deoxyglucose
10/02/2012US8278348 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
10/02/2012US8278347 Therapeutic compounds
10/02/2012US8278346 Di-tin fused thiophene compounds and polymers and methods of making
10/02/2012US8278345 Inhibitors of glutaminyl cyclase
10/02/2012US8278344 Heterocyclic inhibitors of necroptosis
10/02/2012US8278343 Pyrrolidines
10/02/2012US8278342 Therapeutic compounds for blocking DNA synthesis of pox viruses
10/02/2012US8278341 Analogs of indole-3-carbinol and their use as agents against infection
10/02/2012US8278339 Valsartan salts
10/02/2012US8278338 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety
10/02/2012US8278337 Substituted pyridines that are JNK inhibitors
10/02/2012US8278336 Compounds
10/02/2012US8278335 Inhibitors of Janus kinases
10/02/2012US8278334 Cyclic amine BACE-1 inhibitors having a benzamide substituent
10/02/2012US8278333 Crystals of benzoxadiazole derivative
10/02/2012US8278332 Photostabilization of retinoids with alkoxycrylene compounds
10/02/2012US8278331 N-acyl ureas exhibiting anti-cancer and anti-proliferative activities
10/02/2012US8278330 Short duration depot formulations
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278328 Compounds which have activity at M1 receptor and their uses in medicine
10/02/2012US8278327 PDE10 inhibitors and related compositions and methods
10/02/2012US8278326 Inhibitors of protein phosphatase-1 and uses thereof
10/02/2012US8278325 Nitrogen-containing heteroaryl compounds and methods of use thereof
10/02/2012US8278324 Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
10/02/2012US8278323 Opioid antagonists
10/02/2012US8278322 HCV NS3 protease inhibitors
10/02/2012US8278321 Small molecule inhibition of intracellular transport
10/02/2012US8278320 Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
10/02/2012US8278319 Substituted spiroamine compounds
10/02/2012US8278318 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
10/02/2012US8278317 Potassium channel inhibitors
10/02/2012US8278316 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
10/02/2012US8278315 Treating malfunctioning cells in a living mammal by administering a compound which associates with DNA in cells of mammal, said compound comprising a pre-selected element, then irradiating selected region in which malfunctioning cells having said compound associated with DNA are located
10/02/2012US8278314 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/02/2012US8278313 Macrocyclic spiro pyrimidine derivatives
10/02/2012US8278312 Imidazo 1,2-a pyrimidine derivatives for the treatment of diseases such as diabetes
10/02/2012US8278311 Substituted pyrimidine derivatives
10/02/2012US8278308 Diketopiperazine salts for drug delivery and related methods
10/02/2012US8278307 Monocyclic Heteroaryl compounds
10/02/2012US8278306 C-met protein kinase inhibitors
10/02/2012US8278305 Myosin light chain kinase inhibitor compounds, compositions and related methods of use
10/02/2012US8278304 Substituted 4-hydroxypyrimidine-5-carboxamides
10/02/2012US8278303 Phosphine transition metal complex, process for producing same, and anticancer agent
10/02/2012US8278302 Substituted piperidines as CCR3 antagonists
10/02/2012US8278301 2-alkylbenzoxazole carboxamides as 5HT3 modulators
10/02/2012US8278300 Use for PDE5 inhibitors
10/02/2012US8278299 Pyrimidinediamine kinase inhibitors
10/02/2012US8278298 Prophylaxis, therapy of Alzheimer's disease, Pick's disease; administering phenothiazine compound such as methylene blue
10/02/2012US8278297 Protein kinase inhibitors
10/02/2012US8278296 Manipulation of brain CDP-diacylglycerol and uses thereof
10/02/2012US8278295 Amino-heterocyclic compounds
10/02/2012US8278294 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase
10/02/2012US8278293 Diazo bicyclic Smac mimetics and the uses thereof
10/02/2012US8278292 Therapeutic compositions
10/02/2012US8278291 Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
10/02/2012US8278290 Tubulin polymerisation inhibitors
10/02/2012US8278289 Boroxine composition for removal of skin changes
10/02/2012US8278287 siRNA compounds for inhibiting NRF2
10/02/2012US8278286 Use of gp130 activators in diabetic neuropathy
10/02/2012US8278285 Gastric carcinoma gene ZNF312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same
10/02/2012US8278283 6-disubstituted or unsaturated bicyclic nucleic acid analogs
10/02/2012US8278282 Nucleoside analogs for treatment of viral infections
10/02/2012US8278281 Triazole compounds and methods of making and using the same
10/02/2012US8278276 Methods of treating autism
10/02/2012US8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
10/02/2012US8278264 Compositions and methods for enhancing drug delivery across and into ocular tissues
10/02/2012US8278116 Detecting succinylacetone
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8277847 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
10/02/2012US8277846 Complexing agents for compositions containing inclusion complexes
10/02/2012US8277839 Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
10/02/2012US8277836 Carbohydrates mixture
10/02/2012US8277835 Nutritional composition comprising immunoglobulins and oligosaccharides
1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 7860